The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE Edges Up As Smith & Nephew And Lloyds Gain

Thu, 20th Feb 2020 08:37

(Alliance News) - The FTSE 100 was hesitantly in the green early Thursday amid ongoing caution surrounding the coronavirus outbreak, though well-received results from Smith & Nephew and Lloyds Bank were helping to lift the index.

The FTSE 100 was up 3.32 points, or 0.1%, at 7,460.34 early Thursday. The mid-cap FTSE 250 index was up 75.95 points, or 0.4%, at 21,926.81. The AIM All-Share index was up 0.3% at 975.71.

The Cboe UK 100 index was up 0.1% at 12,641.25. The Cboe 250 was up 0.4% at 19,756.90, and the Cboe Small Companies flat at 12,482.35.

In mainland Europe, the CAC 40 in Paris and DAX 30 in Frankfurt both were own 0.1% early Thursday.

"European indices have opened on a slightly softer note, backtracking from a big up day. European shares had already been pricing in the extra Chinese stimulus efforts so are looking ahead to the release of accounts of the latest ECB meeting later," said Jasper Lawler at London Capital Group.

China announced it will cut interest rates in a bid to boost the economy, as it battles the economic fallout of the new coronavirus outbreak.

The reduction in the loan prime rate – one of the preferential rates commercial banks impose on their best customers and which serves as a reference for other lending rates - is the latest measure to help companies struggling through the epidemic.

The one-year LPR was lowered to 4.05% from 4.15%, the People's Bank of China said in a statement. The five-year LPR – on which many lenders base their mortgage rates - was also lowered to 4.75% from 4.8%.

The rate reduction comes as Beijing battles to control a virus epidemic that has infected over 74,500 people in the country.

China reported a big drop in new coronavirus cases on Thursday, fuelling hopes the epidemic is nearing its peak. More than 600 new infections were reported in Wuhan, ground zero of the virus, marking the lowest daily tally since late January, and well down from the 1,749 new cases the day before.

In Tokyo on Thursday, the Nikkei 225 index ended up 0.3%. In China, the Shanghai Composite closed up 1.8%, while the Hang Seng index in Hong Kong closed down 0.2%.

At the top of London's FTSE 100 was Smith & Nephew, the stock up 6.0% after the medical technology firm reported an improved rate of underlying revenue growth for 2019.

Revenue for 2019 amounted to USD5.14 billion, up 4.8% on the year before. Underlying revenue growth was 4.4%, a significant improvement on the 2% recorded for 2018.

Pretax profit was slightly lower at USD743 million versus USD781 million the year before, hampered by increases in selling, general & administrative expenses as well as research & development costs.

The medical technology business recorded a trading profit margin of 22.8%.

For 2020, Smith & Nephew expects underlying revenue growth around 3.5% to 4.5%, which equates to a range of 4.0% to 5.0% on a reported basis. The trading profit margin for 2020 should be at or "slightly above" that achieved in 2019.

Lloyds Banking shares were up 3.1% despite the lender taking a hit to 2019 from a hefty payment protection insurance charge.

Net interest income for 2019 amounted to GBP10.18 billion, down from GBP13.40 billion in 2018.

Pretax profit was down 26% to GBP4.39 billion from GBP5.96 billion a year ago, hurt by payment protection insurance provisions of GBP2.45 billion in the year, versus just GBP750 million in 2019.

"The upside to all of this is that at least the PPI saga looks to be finally behind them, with no further provisions made in this quarter, so there's a big silver lining there," said Michael Hewson at CMC Markets.

At the bottom of the FTSE 100 was Imperial Brands, down 4.1% as the tobacco major went ex-dividend, meaning new buyers no longer qualify for the latest payout. GlaxoSmithKline, down 1.5%, also was ex-dividend.

The economic events calendar on Thursday has UK retail sales figures at 0930 GMT, followed by Irish inflation at 1100 GMT and minutes from the European Central Bank's January meeting at midday.

Ahead of the retail sales data, sterling was quoted at USD1.2888 early Thursday, down from USD1.2947 at the London equities close on Wednesday.

"Today's UK data is likely to receive a lot of attention as markets look for indications that the post-election activity pickup is continuing," said Lloyds Bank.

The euro traded at USD1.0788 early Thursday, soft against USD1.0793 late Wednesday. Against the yen, the dollar was quoted at JPY111.67, up from JPY110.93.

Brent oil was trading at USD59.02 a barrel early Thursday, up from USD58.88 late Wednesday.

Gold was quoted at USD1,609.10 an ounce early Thursday, higher than USD1,605.82 on Wednesday.

"Our best assumption is that the [gold] breakout holds and that prices move in the direction of 1650 per oz in fairly short order," said LCG's Lawler.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.